Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Monash IVF Group Ltd ( (AU:MVF) ).
Monash IVF Group Ltd has appointed Dr. Victoria Atkinson as the new Managing Director and CEO, effective from May 18, 2026. Dr. Atkinson brings over 30 years of experience in healthcare leadership, previously serving as Chief Medical Officer at Healthscope. Her appointment is expected to enhance the company’s focus on clinical and financial strategies, benefiting its stakeholders, including patients and doctors. The company is also in the process of finding a new Chief Financial Officer as Mr. Andrew MacLachlan concludes his interim role.
The most recent analyst rating on (AU:MVF) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Monash IVF Group Ltd stock, see the AU:MVF Stock Forecast page.
More about Monash IVF Group Ltd
Monash IVF Group Ltd is a leading provider of assisted reproductive services and specialist women’s imaging and diagnostic services, operating in Australia, Singapore, Indonesia, and Malaysia.
Average Trading Volume: 2,447,669
Technical Sentiment Signal: Sell
Current Market Cap: A$261.1M
For an in-depth examination of MVF stock, go to TipRanks’ Overview page.